Additional axillary metastases and stage migration in breast cancer patients with micrometastases or submicrometastases in sentinel lymph nodes
β Scribed by Maartje C. van Rijk; Johannes L. Peterse; Omgo E. Nieweg; Hester S. A. Oldenburg; Emiel J. Th. Rutgers; Bin B. R. Kroon
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 91 KB
- Volume
- 107
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND. The feasibility and accuracy of sentinel lymph node (SLN) biopsy in patients with breast cancer after preoperative chemotherapy has been demonstrated in a number of large, singleβinstitution studies. However, a relative contraindication to SLN biopsy after preoperative c
## Abstract The prognostic value of sentinel lymph node (SLN) microβmetastases and the question whether patients with SLN microβmetastases should undergo axillary lymph node dissection remain a matter of great debate. Based on the current literature and on our own data, we provide suggestive eviden
Objectives: Sentinel lymph node biopsy (SLNB) is widely used for staging breast cancer. SLNB accurately determines axillary lymph node status with a low false negative rate. There remains concern that omitting axillary dissection may lead to recurrence in the axilla, and impact long term survival. T
## BACKGROUND. Thirty percent of lymph node negative patients with operable breast carcinoma experience disease recurrence within 10 years. Retrospective serial sectioning of axillary lymph nodes has revealed undetected metastases in 9 -30% of these patients. These occult metastases have been show